RA Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,038,000
| Closed | -$5.97M | – | 90 |
|
|
2024
Q4 | $5.97M | Buy |
+1,038,000
| New | +$5.97M | 0.08% | 82 |
|
|
2022
Q4 | – | Sell |
-896,724
| Closed | -$46.5M | – | 74 |
|
|
2022
Q3 | $46.5M | Hold |
896,724
| – | – | 0.99% | 33 |
|
|
2022
Q2 | $42.4M | Sell |
896,724
-67,488
| -7% | -$3.19M | 1.13% | 30 |
|
|
2022
Q1 | $68.6M | Buy |
+964,212
| New | +$68.6M | 1.5% | 18 |
|
|
2014
Q4 | – | Sell |
-250,000
| Closed | -$9.89M | – | 51 |
|
|
2014
Q3 | $9.89M | Sell |
250,000
-1,289,586
| -84% | -$51M | 1.17% | 19 |
|
|
2014
Q2 | $66.3M | Sell |
1,539,586
-1,492
| -0.1% | -$64.3K | 6.7% | 3 |
|
|
2014
Q1 | $61.6M | Buy |
+1,541,078
| New | +$61.6M | 4.42% | 7 |
|
|
2013
Q3 | – | Sell |
-436,145
| Closed | -$7.72M | – | 32 |
|
|
2013
Q2 | $7.72M | Buy |
+436,145
| New | +$7.72M | 1.02% | 17 |
|